{"id":74451,"date":"2024-03-23T10:22:05","date_gmt":"2024-03-23T10:22:05","guid":{"rendered":"https:\/\/pakistaninewspaperlist.com\/news\/kuehn-law-encourages-investors-of-regeneron-pharmaceuticals-inc-to-contact-law-firm\/"},"modified":"2024-03-23T10:22:05","modified_gmt":"2024-03-23T10:22:05","slug":"kuehn-law-encourages-investors-of-regeneron-pharmaceuticals-inc-to-contact-law-firm","status":"publish","type":"post","link":"https:\/\/pakistaninewspaperlist.com\/news\/kuehn-law-encourages-investors-of-regeneron-pharmaceuticals-inc-to-contact-law-firm\/","title":{"rendered":"Kuehn Law Encourages Investors of Regeneron Pharmaceuticals, Inc. to Contact Law Firm"},"content":{"rendered":"
\n

NEW YORK, March 22, 2024 (GLOBE NEWSWIRE) — Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms.<\/p>\n

If you own REGN <\/strong>please contact\u00a0Justin Kuehn, Esq.\u00a0by email at\u00a0justin@kuehn.law<\/a> or call (833) 672-0814.\u00a0 The consultation and case are free with no obligation to you. Kuehn Law pays all case costs and does not charge its investor clients.<\/strong> Shareholders should contact the firm immediately as there may be limited time to enforce your rights.<\/em>\u00a0\u00a0<\/p>\n

Why Your Participation Matters:<\/strong><\/p>\n

As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. Your investment. Your voice. Your future.<\/em>\u2122\u00a0\u00a0<\/p>\n

For additional information, please visit Shareholder Derivative Litigation – Kuehn Law<\/a>.<\/p>\n

Attorney advertising. Prior results do not guarantee similar outcomes.<\/p>\n

Contacts:
Kuehn Law, PLLC
Justin Kuehn, Esq.
53 Hill Street, Suite 605
Southampton, NY 11968
justin@kuehn.law<\/a>
(833) 672-0814<\/p>\n

\n <\/div>\n","protected":false},"excerpt":{"rendered":"

NEW YORK, March 22, 2024 (GLOBE NEWSWIRE) — Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you own REGN please […]<\/p>\n","protected":false},"author":2,"featured_media":74452,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"fifu_image_url":"https:\/\/ml.globenewswire.com\/Resource\/Download\/83bde11e-8ae3-488a-a2c9-2ce956c44090","fifu_image_alt":"","footnotes":""},"categories":[208],"tags":[],"class_list":["post-74451","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-globenewswire"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t